Shelter HArm Reduction Evaluation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
The proposed study will use mixed methods research to examine overdose and other health-related impacts of harm reduction initiatives in NYC homeless shelters.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult 18 year of age or older
Speak English
Is staying or has stayed in an NYC single-adult shelter that has implemented HRSP interventions
Report past-year drug use
Disqualifiers
None
Trial population
Aims 1a, 1b, and 2: Analysis of administrative data will include the population of individuals in the NYC single-adult homeless services system during 2021-2026. Aim 3: Qualitative interview and focus group participants will include homeless clients who have received one or more of the HRSP interventions and homeless services providers and administrators who have delivered the HRSP interventions.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
80 Participants
are grouped into 4 trial groupsGroup A: Aims 1a, 1b, and 2: Individuals in the NYC Single-Adult Homeless Services
Group B: Aim 3: Homeless Services Clients Staff
Group C: Aim 3: Homeless Services Clients
Group D: Aim 3: Homeless Services Stakeholders
Trial outcomes
Primary outcomes
1
Incidence of Fatal Overdose (OD)
Time frame
Day 0 (Administrative Analysis of Data)2
Incidence of Non-Fatal Overdose (OD)
Time frame
Day 0 (Administrative Analysis of Data)Secondary outcomes
1
Incidence of Substance Use Disorder (SUD) Treatment Initiation
Time frame
Day 0 (Administrative Analysis of Data)2
Incidence of Health Services Utilization
Time frame
Day 0 (Administrative Analysis of Data)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
NYU Langone Health
Lead sponsor
Centers for Disease Control and Prevention
Collaborator
Source ClinicalTrials.gov